Veracyte has launched the Prosigna breast cancer test in the U.S., designed to assess the risk of breast cancer recurrence.
The Prosigna test is a diagnostic tool that helps oncologists determine the likelihood of a patient's breast cancer returning after treatment. This information is crucial for guiding treatment decisions, such as whether to proceed with chemotherapy.
The Prosigna test is a diagnostic tool that helps oncologists determine the likelihood of a patient's breast cancer returning after treatment. This information is crucial for guiding treatment decisions, such as whether to proceed with chemotherapy.
Pick the topics you care about. Get only what matters, on your cadence.